As of 2026-04-03, TScan Therapeutics Inc. (TCRX) trades at a current price of $1.01, marking a 1.94% decline in its most recent trading session. This analysis focuses on key technical levels, prevailing market context, and potential short-term scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company at the time of publication. TCRX, which operates in the engineered T-cell receptor therapy space, has seen muted price action in recent weeks, trading wi
TCRX Stock Analysis: TScan Therapeutics Inc. Biotech at $1 Level Following Small Daily Dip
TCRX - Stock Analysis
3147 Comments
1835 Likes
1
Zakirah
Community Member
2 hours ago
Surely I’m not the only one.
👍 83
Reply
2
Osmara
Elite Member
5 hours ago
My jaw is on the floor. 😮
👍 231
Reply
3
Makaylynn
New Visitor
1 day ago
Anyone else want to talk about this?
👍 166
Reply
4
Mimie
Senior Contributor
1 day ago
Incredible execution and vision.
👍 288
Reply
5
Josgart
Legendary User
2 days ago
Missed the chance… again. 😓
👍 275
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.